Pharmacosurveillance - Pharmacovigilance
Tuesday, June 14, 2022
Sessions parallèles
Sessions parallèles
•
S11
•
1:30 PM
>
3:00 PM
•
Pharmacosurveillance - Pharmacovigilance
•
Amphi Congrès
Sessions parallèles
Modérateurs : Marion LEPELLEY (Grenoble), Annie-Pierre JONVILLE-BERA (Tours)
Conférence invitée
13h30 Quel impact de la crise sanitaire sur la détection et l'analyse du signal en Pharmacovigilance ? - Annie-Pierre JONVILLE-BERA (Tours) et Céline MOUNIER, ANSM (Paris)
Communications libres
•
CO-007
•
CO-007 - Nonsteroidal anti-inflammatory drugs exposure in complicated acute community-acquired bacterial infections, a French multicentre case-control study (ANAIG)
>
G.
Gwenaëlle
VEYRAC
•
CO-008
•
CO-008 - Iatrogenic consequences of drug shortage: the CIRUPT Study from the French Network of Regional Pharmacovigilance Centers
>
D.
Delphine
BOURNEAU-MARTIN
•
CO-009
•
CO-009 - Lack of therapeutic efficacy: a picture of notified cases to the French PV network
>
M-B.
Marie-Blanche
VALNET RABIER
•
CO-010
•
CO-010 - 3 M syndrom (Myasthenia myositis myocarditis) related to nivolumab treatment
>
F.
Frank
ROUBY
•
CO-011
•
CO-011 - Lamotrigine associated serotonin syndrome: analysis of the reports in VigiBase®
>
B.
Basile
CHRÉTIEN
•
CO-012
•
CO-012 - Associations between Th1-mediated diseases and omalizumab: a post-marketing study of the World Health Organization pharmacovigilance database (VigiBase®)
>
B.
Benjamin
BATTEUX
|